Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTZ: Nitazoxanide for COVID-19 Post-exposure Prophylaxis
NCT04788407Phase 4Unknown
- Sponsor
- Fundación Huésped
- Start
- Dec 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Fundación Huésped. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04788407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04788407.